August Webinar - The Recent FDA-Approved NRT Label Changes: Implications for our Practice
Tuesday, August 06, 2013
Posted by: Natalia Gromov
August 14 from 12:30-2:00 PM ET NAQC will host the
FDA-Approved NRT Label Changes: Implications for our Practice.Register now!
The final webinar in NAQC’s 2012/2013 webinar series will focus on the recent
FDA-approved label changes for NRT and the implications for cessation and
quitline practice. After an introduction and background on the decision
to change the labels and a presentation highlighting the specific label changes
by GSK, Inc. (as the holder of the MDA for NRT), we will be joined by a
3-person panel to discuss implications for cessation in general and quitlines
in particular. Dr.
Lowell Dale will discuss his views on the implications of this
decision from a physician/healthcare delivery perspective; Dr. Megan Piper will
provide her perspective on implications for cessation among priority
populations; and Ken
Wassum will present implications on quitline services and
Be sure to join us for a rich panel presentation and lively discussion!